{"@context":"https:\/\/schema.org\/","@type":"CollectionPage","@id":"https:\/\/www.regionalcancercare.org\/news\/category\/leukemia\/#CollectionPage","headline":"Leukemia Category","description":"","url":"https:\/\/www.regionalcancercare.org\/news\/category\/leukemia\/","hasPart":[{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/chronic-lymphocytic-leukemia-2-rcca-oncologists-outline-advances-increasing-survival-quality-of-life\/","headline":"Chronic Lymphocytic Leukemia: 2 RCCA Oncologists Outline Advances Increasing Survival, Quality of Life","url":"https:\/\/www.regionalcancercare.org\/news\/chronic-lymphocytic-leukemia-2-rcca-oncologists-outline-advances-increasing-survival-quality-of-life\/","datePublished":"2025-05-06","dateModified":"2025-07-28","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/chronic-lymphocytic-leukemia-2-rcca-oncologists-outline-advances-increasing-survival-quality-of-life\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/seo-user\/#Person","name":"Advance SEO","url":"https:\/\/www.regionalcancercare.org\/news\/author\/seo-user\/","identifier":7,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/25d521bea98e4070937950c92cd06d2b99615947d3d29e3682593c48f0372431?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/25d521bea98e4070937950c92cd06d2b99615947d3d29e3682593c48f0372431?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2025\/05\/chronic-lymphocytic-leukemia-illustration.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2025\/05\/chronic-lymphocytic-leukemia-illustration.jpg","height":832,"width":1260},"keywords":null},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/leukemia-rates-in-nj\/","headline":"Why Are Leukemia Diagnoses Rising in Northern New Jersey? RCCA Hematologist Jamie Koprivnikar, MD, Provides Expert Insights","url":"https:\/\/www.regionalcancercare.org\/news\/leukemia-rates-in-nj\/","datePublished":"2021-10-14","dateModified":"2025-03-25","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/leukemia-rates-in-nj\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/12\/man-looking-at-large-line-graph.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/12\/man-looking-at-large-line-graph.jpg","height":1000,"width":793},"keywords":null},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/cancers-most-likely-to-necessitate-targeted-monoclonal-immunotherapy\/","headline":"Cancers Most Likely To Benefit From Targeted Monoclonal Immunotherapy","url":"https:\/\/www.regionalcancercare.org\/news\/cancers-most-likely-to-necessitate-targeted-monoclonal-immunotherapy\/","datePublished":"2020-04-21","dateModified":"2025-12-03","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/cancers-most-likely-to-necessitate-targeted-monoclonal-immunotherapy\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctor-And-Patient-Talking.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctor-And-Patient-Talking.jpg","height":600,"width":900},"keywords":["Treatments","Immunotherapy","targeted therapy"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/hematologic-cancer-treatment-options\/","headline":"Treatments for Hematologic Cancers (Blood Cancers)","url":"https:\/\/www.regionalcancercare.org\/news\/hematologic-cancer-treatment-options\/","datePublished":"2020-04-07","dateModified":"2025-12-03","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/hematologic-cancer-treatment-options\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctors-Examining-Blood-Cells.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Doctors-Examining-Blood-Cells.jpg","height":587,"width":900},"keywords":["clinical trials","Treatments","Radiation Therapy","Chemotherapy","Blood and Marrow Transplant"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/how-immunotherapy-works\/","headline":"What Is Immunotherapy \u2013 and Is It Right for You?","url":"https:\/\/www.regionalcancercare.org\/news\/how-immunotherapy-works\/","datePublished":"2019-09-15","dateModified":"2021-11-11","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/how-immunotherapy-works\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Man-Receiving-Immunotherapy-Treatment.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Man-Receiving-Immunotherapy-Treatment.jpg","height":600,"width":900},"keywords":["Treatments","Immunotherapy"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/progress-fight-leukemia-therapeutic-advances-available-right-now-right-nj-conversation-rccas-dr-seth-howard-berk\/","headline":"Progress in the Fight Against Leukemia: Therapeutic Advances Available Right Now \u2013 and Right Here in NJ: A Conversation with RCCA\u2019s Dr. Seth Howard Berk","url":"https:\/\/www.regionalcancercare.org\/news\/progress-fight-leukemia-therapeutic-advances-available-right-now-right-nj-conversation-rccas-dr-seth-howard-berk\/","datePublished":"2018-05-20","dateModified":"2021-11-11","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/progress-fight-leukemia-therapeutic-advances-available-right-now-right-nj-conversation-rccas-dr-seth-howard-berk\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Seth-H-Berk.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Seth-H-Berk.jpg","height":900,"width":600},"keywords":["Treatments"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/car-t-cell-therapy-new-hope-for-remission-in-leukemia\/","headline":"CAR T-Cell Therapy: New Hope for Remission in Leukemia","url":"https:\/\/www.regionalcancercare.org\/news\/car-t-cell-therapy-new-hope-for-remission-in-leukemia\/","datePublished":"2018-02-10","dateModified":"2021-11-11","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/car-t-cell-therapy-new-hope-for-remission-in-leukemia\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Lamba-Gurpreet.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Lamba-Gurpreet.jpg","height":900,"width":600},"keywords":["Treatments","T-Cell Therapy"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/targeting-treatments-chronic-lymphocytic-leukemia\/","headline":"Targeting Treatments for Chronic Lymphocytic Leukemia","url":"https:\/\/www.regionalcancercare.org\/news\/targeting-treatments-chronic-lymphocytic-leukemia\/","datePublished":"2018-02-08","dateModified":"2021-11-11","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/targeting-treatments-chronic-lymphocytic-leukemia\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Joel-Silver.jpg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/09\/Joel-Silver.jpg","height":900,"width":600},"keywords":["Treatments"]},{"@type":"BlogPosting","@id":"https:\/\/www.regionalcancercare.org\/news\/regional-cancer-care-associates-rcca-researchers-from-john-theurer-cancer-center-present-leading-edge-clinical-data-in-blood-cancers-at-american-society-of-hematology-meeting\/","headline":"Regional Cancer Care Associates (RCCA) Researchers from John Theurer Cancer Center Present Leading-Edge Clinical Data in Blood Cancers at American Society of Hematology Meeting","url":"https:\/\/www.regionalcancercare.org\/news\/regional-cancer-care-associates-rcca-researchers-from-john-theurer-cancer-center-present-leading-edge-clinical-data-in-blood-cancers-at-american-society-of-hematology-meeting\/","datePublished":"2015-12-09","dateModified":"2021-12-14","mainEntityOfPage":"https:\/\/www.regionalcancercare.org\/news\/regional-cancer-care-associates-rcca-researchers-from-john-theurer-cancer-center-present-leading-edge-clinical-data-in-blood-cancers-at-american-society-of-hematology-meeting\/","author":{"@type":"Person","@id":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/#Person","name":"ceastway","url":"https:\/\/www.regionalcancercare.org\/news\/author\/ceastway\/","identifier":5,"image":{"@type":"ImageObject","@id":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/007b7979610c70c3cd4b24ed960fb78ff62c0b68401d393e79cb483d56812050?s=96&d=mm&r=g","height":96,"width":96}},"publisher":{"@type":"Organization","name":"Regional Cancer Care Associates","logo":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/logo.svg","width":506,"height":228}},"image":{"@type":"ImageObject","@id":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/COA.png","url":"https:\/\/www.regionalcancercare.org\/wp-content\/uploads\/2021\/08\/COA.png","height":"193","width":"200"},"keywords":["Press Release"]}],"about":["Lymphoma","Leukemia","Blood Disorders"]}